Status:
COMPLETED
Action of Synbiotics on Irradiated GI Mucosa in Rectal Cancer Treatment
Lead Sponsor:
Region Skane
Conditions:
Rectal Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of this study is to investigate how bacteria and fibre interact with the epithelial cells of the gastrointestinal mucosa to reduce inflammation and to diminish tissue damage caused by radiatio...
Detailed Description
Thirty patients diagnosed with rectal cancer receiving short term radiation therapy 25 Gray (Gy) during one week preoperatively will be examined. The patients will be divided into three groups with te...
Eligibility Criteria
Inclusion
- Rectal cancer/Adenocarcinoma recti
- Informed Consent explained orally and written, understood, agreed and signed
Exclusion
- Diabetes Mellitus
- Inflammatory bowel disease
- Previous radiation to pelvis area
- Ongoing steroid or immunosuppressive therapy
- Ongoing antibiotics therapy
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03420443
Start Date
November 1 2008
End Date
November 1 2015
Last Update
February 5 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.